{Reference Type}: Journal Article
{Title}: Temporal Trends of Inflammatory Bowel Diseases in Taiwan from 2016 to 2020: A Population-Based Study.
{Author}: Kuo CJ;Lin CY;Le PH;Kuo YW;Hsu CM;Lai MW;Lin WR;Chang ML;Su MY;Chiu CT;Chang CJ;
{Journal}: Dig Dis Sci
{Volume}: 0
{Issue}: 0
{Year}: 2024 Jun 29
{Factor}: 3.487
{DOI}: 10.1007/s10620-024-08518-2
{Abstract}: <B>BACKGROUND: </B>There are scanty population-based studies investigating the incidence and prevalence rates of inflammatory bowel disease (IBD) in Taiwan.<BR><B>OBJECTIVE: </B>This study aimed to estimate the nationwide prevalence and incidence of IBD and identify its noticeable trends in Taiwan between 2016 and 2020.<BR><B>METHODS: </B>A retrospective study by analyzing the data from the National Health Insurance Research Database of Taiwan.<BR><B>RESULTS: </B>A total of 2595 patients with catastrophic IBD illness were registered from 2016 to 2020 in Taiwan (CD, 880; UC, 1715). The male-to-female ratio in the study sample was 1.83:1 for CD and 1.69:1 for UC. The median age of those registered with CD and UC was 37 and 47 years, respectively. The incidence rate of CD was 0.65 per 100,000 persons in 2016 and it was increased to 0.81 per 100,000 persons in 2020. The incidence rate of UC was 1.16 per 100,000 persons in 2016 and it was increased to 1.53 in 2020. Overall, the incidence of IBD was increase from 1.81 per 100,000 persons to 2.34 per 100,000 persons between 2016 and 2020. Overall, the prevalence rates of IBD was increase from 14.95 per 100,000 persons to 20.02 per 100,000 persons between 2016 and 2020.<BR><B>CONCLUSIONS: </B>The epidemiological stages of IBD in Taiwan was considered in the acceleration in incidence stage, during which incidence rises and prevalence is relatively low. Understanding these geographical differences is important for the rising global burden of IBD.